Key Highlights
- Cathie Wood’s ARK Invest acquired $18.4 million worth of Coinbase stock distributed across three exchange-traded funds
- The investment firm divested approximately $29 million in Robinhood stock, despite the position remaining among ARKK’s top four holdings
- ARK disposed of $33 million in Roku stock while adding $46 million to its Eli Lilly position
- Robinhood shares surged 8.78% while Coinbase dropped 2.57% during Wednesday’s trading session
- The Coinbase purchases followed the company’s launch of tokenized equities and AI-driven advisory tools
Cathie Wood’s investment firm executed several significant portfolio adjustments on Wednesday, June 17, increasing exposure to Coinbase and Eli Lilly while reducing holdings in Robinhood and Roku.
The firm accumulated 111,799 Coinbase shares spread across its ARKK, ARKW, and ARKF exchange-traded funds, representing approximately $18.4 million in total value. The cryptocurrency exchange’s stock declined 2.57% that day, settling at $164.92. The share price has fallen nearly 13% over the trailing 30-day period.
Additionally, ARK accumulated 236,759 Block Inc. shares via its ARKK ETF, valued at approximately $17.2 million. Block’s stock also finished the session in negative territory, declining 2.46% to close at $72.84.
Robinhood and Roku Face ARK Selloff
On the divestment front, ARK liquidated 275,572 Robinhood shares from its ARKK fund, totaling approximately $26.7 million. This transaction came after the firm had already shed 167,741 Robinhood shares the prior Thursday, indicating a deliberate downsizing of this holding.
Despite ARK’s selling activity, Robinhood shares performed exceptionally well, climbing 8.78% to finish at $105.20. The trading app company continues to represent ARKK’s fourth-largest portfolio allocation at 4.87%, with a total value of $339.6 million.
ARK simultaneously disposed of 239,267 Roku shares across its ARKK, ARKW, and ARKF funds, amounting to roughly $33 million. This sale extended a pattern of Roku reductions, including a substantial disposal of 665,136 shares earlier that week on Monday.
Pharmaceutical Giant Eli Lilly Gets Major Investment
The day’s most substantial acquisition targeted the pharmaceutical sector. ARK purchased 41,138 Eli Lilly shares through its ARKK and ARKG ETFs, deploying approximately $46.2 million. Eli Lilly shares declined 0.94% during the session, closing at $1,112.
Coinbase now occupies the eighth-largest position within ARKK’s portfolio, accounting for 3.71% of fund assets at $258.6 million.
The timing of ARK’s Coinbase purchases aligned with major product rollouts from the company. One day prior, on Tuesday, Coinbase revealed plans to enable users to purchase, trade, and hold tokenized representations of U.S. equities. The platform simultaneously introduced a significant system upgrade incorporating an AI-powered advisory service and consolidated global liquidity across both spot cryptocurrency and derivatives trading platforms.
Benchmark Equity Research maintained its Buy recommendation on Coinbase shares following these developments, noting that the new offerings demonstrated the company’s evolution beyond pure cryptocurrency trading toward comprehensive financial infrastructure services.
Robinhood also captured headlines Tuesday with an announcement regarding workforce reductions affecting 10% of full-time employees. Company leadership framed the decision as strategic repositioning toward a more efficient operational structure.
Bernstein analysts suggested earlier this week that Robinhood stands to gain from increased prediction market engagement connected to World Cup events, with daily transaction volume jumping from $2.2 billion on June 11 to $4.8 billion by June 12.
ARK executed additional smaller transactions, including purchases of Alamar Biosciences and Generate Biomedicines shares, while reducing exposure to Strata Critical Medical and Twist Bioscience.


